Showing results (121-130 of 245) with videos related to
Sort By:
Pageof 25
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.Cancers|February 11, 2023
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical PracticeValentina Fanotto, Francesca Salani, Caterina Vivaldi, et al.Anticancer Research|April 12, 2015
Bevacizumab and first-line chemotherapy for older patients with advanced colorectal cancer: final results of a Community-based Observational Italian StudyStefania Eufemia Lutrino, Francesca Bergamo, Marta Schirripa, et al.Plos One|October 23, 2015
Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records ReviewJörg Trojan, Laurent Mineur, Jiří Tomášek, et al.Anti-Cancer Agents in Medicinal Chemistry|October 10, 2013
Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patientsMassimiliano Berretta, Giuseppe Aprile, Guglielmo Nasti, et al.Cancer|November 6, 2015
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)Francesco Leone, Donatella Marino, Stefano Cereda, et al.Critical Reviews in Oncology/Hematology|June 13, 2017
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?Giuseppe Aprile, Francesca V Negri, Francesco Giuliani, et al.Journal of Experimental & Clinical Cancer Research : CR|December 24, 2015
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published dataLorenzo Fornaro, Caterina Vivaldi, Stefano Cereda, et al.BMC Cancer|November 30, 2017
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records reviewJ Han van Krieken, George Kafatos, James Bennett, et al.Clinical Medicine Insights. Oncology|August 22, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, et al.Pageof 25